» Articles » PMID: 16262211

Intermediate Phenotypes in Schizophrenia: a Selective Review

Overview
Specialty Neurology
Date 2005 Nov 3
PMID 16262211
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Studies aiming to identify susceptibility genes for schizophrenia and other complex psychiatric disorders are faced with the confounds of subjective clinical criteria, commonly occurring phenocopies, significant between-subject variability of candidate traits, and the likelihood of allelic and locus heterogeneity that has been shown to define the genetics of other complex human brain and somatic disorders. Additionally, research aimed at identification of the molecular origins of schizophrenia must also deal with the confounding nature of the human brain. Unlike organs with a few common cellular phenotypes, transcriptomes, and proteomes, individual neurons are often distinct from one another in all of these respects. In this review, we present recent work testing the assumption that studies of genetic susceptibility in complex polygenic disorders such as schizophrenia might be enhanced by the identification of intermediate phenotypes related to more fundamental aspects of brain development and function. Progress in the identification of meaningful intermediate phenotypes in schizophrenia has been made possible by the advent of newer methods in cognitive neuroscience and neuroimaging, and the use of combined multimodal techniques.

Citing Articles

Unveiling Promising Neuroimaging Biomarkers for Schizophrenia Through Clinical and Genetic Perspectives.

Guo J, He C, Song H, Gao H, Yao S, Dong S Neurosci Bull. 2024; 40(9):1333-1352.

PMID: 38703276 PMC: 11365900. DOI: 10.1007/s12264-024-01214-1.


Parkinson's Disease Risk Variant rs9638616 is Non-Specifically Associated with Altered Brain Structure and Function.

Welton T, Teo T, Chan L, Tan E, Tan L J Parkinsons Dis. 2024; 14(4):713-724.

PMID: 38640170 PMC: 11191537. DOI: 10.3233/JPD-230455.


Quantitative trait locus analysis for endophenotypes reveals genetic substrates of core symptom domains and neurocognitive function in autism spectrum disorder.

Lee I, Koelliker E, Kong S Transl Psychiatry. 2022; 12(1):407.

PMID: 36153334 PMC: 9509384. DOI: 10.1038/s41398-022-02179-3.


Altered Cerebral Curvature in Preterm Infants Is Associated with the Common Genetic Variation Related to Autism Spectrum Disorder and Lipid Metabolism.

Kim H, Ahn J, Lee J, Jang Y, Kim Y, Kim J J Clin Med. 2022; 11(11).

PMID: 35683524 PMC: 9181724. DOI: 10.3390/jcm11113135.


Real-time cognitive performance and positive symptom expression in schizophrenia.

Dupuy M, Abdallah M, Swendsen J, Nkaoua B, Chanraud S, Schweitzer P Eur Arch Psychiatry Clin Neurosci. 2021; 272(3):415-425.

PMID: 34287696 PMC: 8938338. DOI: 10.1007/s00406-021-01296-2.


References
1.
Beutler E . The HFE Cys282Tyr mutation as a necessary but not sufficient cause of clinical hereditary hemochromatosis. Blood. 2003; 101(9):3347-50. DOI: 10.1182/blood-2002-06-1747. View

2.
Hofer A, Weiss E, Golaszewski S, Siedentopf C, Brinkhoff C, Kremser C . An FMRI study of episodic encoding and recognition of words in patients with schizophrenia in remission. Am J Psychiatry. 2003; 160(5):911-8. DOI: 10.1176/appi.ajp.160.5.911. View

3.
Callicott J . An expanded role for functional neuroimaging in schizophrenia. Curr Opin Neurobiol. 2003; 13(2):256-60. DOI: 10.1016/s0959-4388(03)00041-2. View

4.
Fujii Y, Shibata H, Kikuta R, Makino C, Tani A, Hirata N . Positive associations of polymorphisms in the metabotropic glutamate receptor type 3 gene (GRM3) with schizophrenia. Psychiatr Genet. 2003; 13(2):71-6. DOI: 10.1097/01.ypg.0000056682.82896.b0. View

5.
Aronica E, Gorter J, Ijlst-Keizers H, Rozemuller A, Yankaya B, Leenstra S . Expression and functional role of mGluR3 and mGluR5 in human astrocytes and glioma cells: opposite regulation of glutamate transporter proteins. Eur J Neurosci. 2003; 17(10):2106-18. DOI: 10.1046/j.1460-9568.2003.02657.x. View